Pursuant to the Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular No. SEBI/HO/MIRSD/MIRSD-RTAMB/P/CIR /2022/8 dated January 25, 2022, Neuland Laboratories has informed that the Company has approved issuance of Letter of Confirmation in lieu of share certificate(s) reported lost/misplaced by the shareholder(s), as per the details enclosed.
The above information is a part of company’s filings submitted to BSE.